首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Screening and identification of potential active components in Ophiopogonis Radix against atherosclerosis by biospecific cell extraction
【24h】

Screening and identification of potential active components in Ophiopogonis Radix against atherosclerosis by biospecific cell extraction

机译:筛选和鉴定蛋白酶粥样硬化抗动脉粥样硬化潜在活性成分的筛选及鉴定

获取原文
获取原文并翻译 | 示例
       

摘要

Atherosclerosis is a chronic disease and an important pathological process associated with cardiovascular disease. Endothelial dysfunction, vascular smooth muscle cells (VSMCs) proliferation and neutrophil activation are involved in the development of atherosclerosis. Ophiopogonis Radix is a common traditional Chinese medicine use to treat cardiovascular diseases, however, its active constituents remain to be elucidated. In this study, primary vascular endothelial cells, primary VSMCs and neutrophils were prepared, and extract of Ophiopogonis Radix (EOR) was investigated to ameliorate H2O2 induced reactive oxygen species (ROS) and nitric oxide (NO) production. The results showed that EOR decreased levels of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1, its protective effects against oxidative damage of endothelia and endothelial dysfunction. Additionally, EOR treatment inhibited oxidized low-density lipoprotein-induced VSMC proliferation, phorbol-12-myristate-13-acetate-mediated ROS production and neutrophil activation, malondialdehyde production, and decreased superoxide dismutase activity and myeloperoxidase release. By HPLC-Q-TOF-MS/MS analysis, 51 compounds in EOR were identified including 22 saponins and 24 homo-isoflavonoids. Then biospecific cell extraction and LC-MS technique were employed to screening the antiatherosclerosis active components in Ophiopogonis Radix. After co-cultured with EOR, the multi-effective active constituents including four saponins and two homoisoflavonoids were acquired and subsequently verified to restore properties including endothelial injury, VSMC proliferation and neutrophil activation, indicating that these compounds may be multi-effective active constituents that were responsible for atherosclerosis and the cardiovascular protection of Ophiopogonis Radix.
机译:动脉粥样硬化是一种慢性疾病和与心血管疾病相关的重要病理过程。内皮功能障碍,血管平滑肌细胞(VSMC)增殖和中性粒细胞激活参与动脉粥样硬化的发展。 Ophiopogonis adrix是一种常见的中药用来治疗心血管疾病,然而,其活性成分仍然阐明。在该研究中,制备原发性血管内皮细胞,初级VSMC和中性粒细胞,并研究了Ophiopogonis adrix(EOR)的提取物,以改善H 2 O 2诱导的活性氧(ROS)和一氧化氮(NO)产生。结果表明,EOR降低了细胞间粘附分子-1和血管细胞粘附分子-1的水平,其对内皮和内皮功能障碍的氧化损伤的保护作用。另外,EOR处理抑制氧化低密度脂蛋白诱导的VSMC增殖,Phorbol-12-Myristerate-13-乙酸盐介导的ROS产生和中性粒细胞活化,丙二醛生产和降低的超氧化物歧化酶活性和髓氧化酶释放。通过HPLC-Q-TOF-MS / MS分析,鉴定了51个EOR中的化合物,其中包括22个皂苷和24个同源异戊类异戊类异戊烷。然后,使用生物特异性细胞萃取和LC-MS技术,用于筛选Ophiopogonis radix中的抗真菌粥样硬化活性成分。在用EOR共培养后,获得包括四个皂苷和两个均异叶鲸醛醛醛醛的多有效活性成分,随后验证,以恢复包括内皮损伤,VSMC增殖和中性粒细胞活化的性质,表明这些化合物可以是多功能活性成分负责动脉粥样硬化和渗透蛋白酶的心血管保护。

著录项

  • 来源
  • 作者单位

    China Pharmaceut Univ Sch Tradit Chinese Pharm Jiangsu Key Lab TCM Evaluat &

    Translat Res Nanjing 211198 Jiangsu Peoples R China;

    China Pharmaceut Univ Sch Tradit Chinese Pharm Jiangsu Key Lab TCM Evaluat &

    Translat Res Nanjing 211198 Jiangsu Peoples R China;

    China Pharmaceut Univ Sch Tradit Chinese Pharm Jiangsu Key Lab TCM Evaluat &

    Translat Res Nanjing 211198 Jiangsu Peoples R China;

    China Pharmaceut Univ Sch Tradit Chinese Pharm Jiangsu Key Lab TCM Evaluat &

    Translat Res Nanjing 211198 Jiangsu Peoples R China;

    China Pharmaceut Univ Sch Tradit Chinese Pharm Jiangsu Key Lab TCM Evaluat &

    Translat Res Nanjing 211198 Jiangsu Peoples R China;

    China Pharmaceut Univ Sch Tradit Chinese Pharm Jiangsu Key Lab TCM Evaluat &

    Translat Res Nanjing 211198 Jiangsu Peoples R China;

    China Pharmaceut Univ Sch Tradit Chinese Pharm Jiangsu Key Lab TCM Evaluat &

    Translat Res Nanjing 211198 Jiangsu Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物化学技术;
  • 关键词

    Extract of Ophiopogonis Radix; Atherosclerosis; Biospecific cell extraction; Active components; HPLC-Q-TOF-MS/MS;

    机译:Ophiopogonis adrain的提取物;动脉粥样硬化;生物兴趣细胞萃取;活性成分;HPLC-Q-TOF-MS / MS;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号